Skip to main content
Abbisko Cayman Limited logo

Abbisko Cayman Limited — Investor Relations & Filings

Ticker · 2256 ISIN · KYG0028A1085 LEI · 655600UAX2YV03PRXN31 HKEX Manufacturing
Open in API
Filings indexed 402 across all filing types
Latest filing 2026-04-28 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 2256

About Abbisko Cayman Limited

http://www.abbisko.com

Abbisko Cayman Limited is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule therapies. The company leverages a robust in-house R&D engine and a multi-dimensional discovery platform to advance a rich pipeline focused primarily on oncology, encompassing both precision-oncology and immuno-oncology candidates. Key product candidates include pimicotinib, which has shown positive topline results for the treatment of tenosynovial giant cell tumor (TGCT). Abbisko aims to develop novel treatments that address critical unmet medical needs for patients globally.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 1% confidence The document is the Hong Kong Exchange “Next Day Disclosure Return” FF305, detailing changes in issued shares (new placing under general mandate) and treasury shares (repurchases for cancellation). This is a mandatory stock exchange disclosure of share capital changes under Main Board Rule 13.25A/GEM Rule 17.27A, covering new share issues and share repurchases. It therefore falls under the “Share Issue/Capital Change” category.
2026-04-28 English
COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement by Abbisko Cayman Limited regarding the completion of a placing of 42,900,000 new shares under the company’s general mandate. It provides details of the number of shares issued, placing price, use of proceeds, and effects on shareholding structure—all hallmarks of a share issue notice. As it specifically relates to the issuance of new shares (rather than broader fundraising commentary), it fits the definition of Share Issue/Capital Change (Code: SHA).
2026-04-28 English
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a reminder letter to non-registered shareholders about the arrangement for electronic dissemination of corporate communications (annual reports, interim reports, notices, circulars, proxy forms, etc.) and how to opt for printed copies. It is neither an actual annual/interim report nor a notice of dividend, board change, financing, nor a Q&A transcript; rather it is a regulatory announcement to shareholders about communication procedures. No specific financial data or voting matters are presented. Therefore it best fits the catch-all “Regulatory Filings” category.
2026-04-28 English
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a notification letter to shareholders about the electronic dissemination arrangements for all future corporate communications (annual report, interim report, notices, circulars, proxy forms, etc.). It does not contain financial results, management discussion, proxy solicitation for a specific meeting, or any form of performance release. It is not an AGM presentation, dividend notice, or a full report, but rather a regulatory-style announcement about how reports and notices will be distributed going forward. This falls under the general regulatory announcement/fallback category.
2026-04-28 English
FORM OF PROXY FOR THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for the company’s 2025 Annual General Meeting, providing shareholders with voting instructions, resolution details, and procedures for appointing a proxy. It is sent to solicit proxies and votes ahead of the meeting, rather than reporting results or presenting financials. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-28 English
NOTICE OF THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the official Notice of the Annual General Meeting, listing the date, time, location, resolutions to be voted on, and proxy appointment instructions. It is sent to shareholders to provide meeting information and solicit votes (including proxy forms and voting mechanics). This aligns with the definition of Proxy Solicitation & Information Statement (PSI), rather than a presentation, financial report, or voting results announcement.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.